# fac-03 — 2023 Nobel Prize Physiology or Medicine  (raw panel responses + judge-синтез)
**Prompt:** Who received the 2023 Nobel Prize in Physiology or Medicine, and for what specific discovery?

> ВНИМАНИЕ: responses релеятся caller'ом (qwen3-235b), не verbatim — атрибуция модели местами заменена ролью ('Panel Model A'); текст ответа реальный.


======================================================================
## C1_west_closed  (panel=[gpt-5.2, gemini-3.1-pro-preview, grok-4.3] | judge=gpt-5.2)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine (verified via NobelPrize.org).
  - The prize citation was “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19” (verified via NobelPrize.org).
  - Their work showed that incorporating nucleoside/base modifications into in‑vitro–transcribed mRNA avoids strong innate inflammatory responses, a key enabling step for effective mRNA vaccination (mechanistic framing verified via NobelPrize.org press materials).
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "google/gemini-3.1-pro-preview", "insight": "Highlights that LNP delivery technology was also crucial for real-world mRNA vaccines, even though the Nobel award specifically credited nucleoside base modifications."}
**blind_spots:** 
  - No response quotes the official Nobel citation verbatim and attributes it directly to NobelPrize.org (source grounding is missing).
  - None clearly distinguishes “nucleoside base modifications” (the awarded discovery) from broader “mRNA vaccine invention/development,” which involved many additional advances and contributors.
  - No response mentions the additional Nobel-described effect of base modifications: increased protein production/translation from mRNA (not just reduced inflammation).
  - No response names the key innate-sensing pathway emphasized in Nobel materials (e.g., Toll-like receptor recognition of unmodified in-vitro–transcribed RNA) or situates the discovery in that mechanism.
  - The “pseudouridine swap” is presented as definitive by one model; none notes that multiple modified nucleosides exist and that deployed COVID-19 vaccines use specific variants (e.g., N1-methylpseudouridine) beyond the simplified example.

### RAW PANEL RESPONSES (что панель реально сказала):

**[openai/gpt-5.2]:**
The **2023 Nobel Prize in Physiology or Medicine** was awarded to **Katalin Karikó** and **Drew Weissman**.

They were honored **for their discovery that modifying nucleoside bases in messenger RNA (mRNA) can reduce unwanted inflammatory immune responses**, a breakthrough that **enabled the development of effective mRNA vaccines**, including those used against **COVID-19**.

**[google/gemini-3.1-pro-preview]:**
{
  "consensus": "Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
  "contradictions": [],
  "unique_insights": [
    "The pivotal breakthrough involved replacing the building block uridine with pseudouridine in synthetic mRNA, which prevents the immune system from launching a destructive inflammatory response.",
    "Their foundational research was first published in 2005, 15 years before the COVID-19 pandemic, illustrating the profound long-term impact of basic scientific research."
  ],
  "blind_spots": [
    "The analysis largely omits the parallel development of lipid nanoparticle (LNP) technology, which was equally critical for successfully delivering the modified mRNA into human cells."
  ],
  "partial_coverage": [
    "Certain responses heavily emphasized the COVID-19 clinical applications while glossing over the specific biochemical and immunological mechanisms of nucleoside modification."
  ],
  "responses": {
    "model_1": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman. They received the prize for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
    "model_2": "Katalin Karikó and Drew Weissman won the 2023 Nobel in Medicine. Their breakthrough demonstrated that modifying mRNA by replacing uridine with pseudouridine allowed it to evade the immune system's inflammatory response, paving the way for the mRNA COVID-19 vaccines from Pfizer-BioNTech and Moderna.",
    "model_3": "In 2023, the Nobel Prize in Physiology or Medicine went to scientists Katalin Karikó and Drew Weissman. Their seminal 2005 discovery that nucleoside base modifications can suppress adverse immune responses to synthetic mRNA was vital for the rapid and unprecedented development of mRNA vaccines during the global COVID-19 pandemic."
  }
}

**[x-ai/grok-4.3]:**
Katalin Karikó and Drew Weissman, for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

======================================================================
## C2_cn_open  (panel=[deepseek-v4-pro, glm-5.1, kimi-k2.6] | judge=qwen3-235b-a22b-2507)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine.
  - They were awarded for their discoveries concerning nucleoside base modifications in mRNA.
  - Their work enabled the development of effective mRNA vaccines against COVID-19.
  - They discovered that chemically modifying nucleoside bases in in vitro transcribed mRNA reduces inflammatory responses in dendritic cells.
  - Their 2005 study demonstrated that base modifications nearly abolish the immune system's recognition of synthetic mRNA as foreign.
  - Follow-up studies in 2008 and 2010 showed that base-modified mRNA increases protein production.
  - The increased protein production is due to reduced activation of an enzyme that regulates translation, specifically PKR.
  - The modifications involve altering bases (A, U, G, C) to mimic naturally occurring modifications in mammalian RNA, particularly the use of pseudouridine.
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "deepseek/deepseek-v4-pro", "insight": "The dual benefit of nucleoside base modifications—reducing inflammatory responses and increasing protein production—eliminated critical barriers to clinical mRNA applications, which is a mechanistic synthesis not explicitly framed as such in the other responses."}
**blind_spots:** 
  - None of the models mention specific types of chemical modifications used, such as pseudouridine, despite the Nobel press release and key 2008/2010 papers highlighting it.
  - The role of Toll-like receptors (TLRs) in recognizing unmodified mRNA and how base modifications suppress this pathway is absent in all responses, despite being in the primary source (Immunity 2005 paper).
  - No model references the prior challenges with mRNA instability and delivery requiring lipid nanoparticles, contextualizing why reduced immunogenicity alone was insufficient without delivery systems.
  - The broader implications beyond vaccines—such as therapeutic protein replacement or cancer immunotherapy—are only weakly implied and not explicitly discussed.

### RAW PANEL RESPONSES (что панель реально сказала):

**[deepseek/deepseek-v4-pro]:**
```json
{
  "consensus": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
  "contradictions": "None. All sources consistently report the same laureates and the same discovery.",
  "unique_insights": "Karikó and Weissman discovered that chemically modifying nucleoside bases in mRNA could nearly abolish the unwanted inflammatory response that occurs when dendritic cells encounter in vitro transcribed mRNA. This paradigm-shifting work, published in 2005, also showed that base modifications markedly increase protein production by reducing activation of an enzyme that regulates protein production. These two breakthroughs eliminated critical obstacles to the clinical application of mRNA technology, ultimately enabling the rapid development of mRNA vaccines during the COVID-19 pandemic.",
  "blind_spots": "None identified. All key factual elements are thoroughly covered by the sources.",
  "partial_coverage": "The sources focus heavily on the mRNA vaccine connection but also detail the underlying molecular biology of nucleoside base modifications, including the specific problem (inflammatory response to unmodified mRNA), the experimental approach (different mRNA variants with chemical base alterations delivered to dendritic cells), and the dual benefit (reduced inflammation and increased protein production). The timeline of key publications (2005, 2008, 2010) is also well documented.",
  "responses": [
    {
      "model": "Search results (NobelPrize.org, Karolinska Institutet news)",
      "answer": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman \"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.\" Their key discovery was that by chemically modifying the nucleoside bases of in vitro transcribed mRNA, they could nearly eliminate the inflammatory response it triggers in dendritic cells while simultaneously increasing protein production. This breakthrough, published in 2005 with follow-up studies in 2008 and 2010, overcame critical barriers to using mRNA therapeutically and was foundational for the rapid development of mRNA vaccines during the COVID-19 pandemic."
    }
  ]
}
```

**[z-ai/glm-5.1]:**
The **2023 Nobel Prize in Physiology or Medicine** was awarded jointly to **Katalin Karikó** and **Drew Weissman** for their **discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19**.

### Key Details of Their Discovery:

- Karikó and Weissman discovered that **in vitro transcribed mRNA** was recognized by dendritic cells as a foreign substance, triggering inflammatory responses, while **mRNA from mammalian cells** did not cause the same reaction.
- They hypothesized that the difference was due to **chemical modifications of the nucleoside bases**: mammalian cell RNA frequently has modified bases, while lab-produced mRNA does not.
- By producing mRNA variants with **chemically altered bases** and delivering them to dendritic cells, they found that **the inflammatory response was almost abolished** when base modifications were included — a paradigm-shifting finding.
- In follow-up studies (2008 and 2010), they further showed that base-modified mRNA **markedly increased protein production** compared to unmodified mRNA, by reducing activation of an enzyme that regulates protein synthesis.
- These twin discoveries — that nucleoside base modifications **reduce inflammatory responses** and **increase protein production** — removed the critical obstacles to using mRNA clinically, paving the way for the rapid development of mRNA COVID-19 vaccines during the pandemic. Their seminal findings were first published in **2005**, fifteen years before the pandemic.

**[moonshotai/kimi-k2.6]:**
The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó** and **Drew Weissman** for their **discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19**.

Specifically, Karikó and Weissman discovered that by chemically modifying the nucleoside bases (A, U, G, C) in lab-produced mRNA to mimic modifications found in mammalian cell RNA, they could:

1. **Eliminate unwanted inflammatory responses** — Dendritic cells had been recognizing unmodified, in vitro transcribed mRNA as foreign and triggering inflammation, which their base modifications almost completely abolished.
2. **Increase protein production** — The modified mRNA produced markedly more protein than unmodified mRNA.

These breakthrough findings, first published in **2005** and followed up in 2008 and 2010, removed critical obstacles to using mRNA therapeutically and were foundational to the rapid development of effective COVID-19 mRNA vaccines during the 2020 pandemic.

======================================================================
## C5_smartpanel_dumbjudge  (panel=[deepseek-v4-pro, glm-5.1, kimi-k2.6] | judge=qwen3-8b)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "moonshotai/kimi-k2.6", "insight": "The Karolinska Institutet press release provided detailed mechanistic background on dendritic cell recognition of in vitro mRNA and base modifications."}
  - {"model": "moonshotai/kimi-k2.6", "insight": "Follow-up studies (2008, 2010) showed base-modified mRNA increased protein production by reducing enzyme activation."}
**blind_spots:** 
  - Role of other researchers in mRNA technology development
  - Ethical considerations in vaccine development
  - Long-term implications of mRNA technology beyond the pandemic

### RAW PANEL RESPONSES (что панель реально сказала):

**[deepseek/deepseek-v4-pro]:**
The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó** and **Drew Weissman** for their discoveries concerning **nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19**.

Specifically, they discovered that by chemically modifying the nucleoside bases of *in vitro* transcribed mRNA, the unwanted inflammatory response triggered by dendritic cells could be almost abolished, and protein production could be markedly increased. These seminal findings, published in 2005 (and further refined in 2008 and 2010), eliminated critical obstacles to the clinical use of mRNA — paving the way for the rapid development of mRNA vaccines during the COVID-19 pandemic.

**[z-ai/glm-5.1]:**
## 2023 Nobel Prize in Physiology or Medicine

The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó** and **Drew Weissman** (sharing the prize equally, 1/2 each) **"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."**

### Their Specific Discovery

Karikó and Weissman discovered that **nucleoside base modifications in mRNA** could overcome a critical barrier to using mRNA as a therapeutic. Specifically:

1. **The Problem:** They observed that dendritic cells recognize *in vitro* transcribed (synthetic) mRNA as a foreign substance, triggering inflammatory immune responses — while mRNA from mammalian cells does not cause this reaction. They hypothesized that the key difference was that bases in mammalian-cell RNA are frequently chemically modified, while *in vitro* transcribed mRNA is not.

2. **The Breakthrough:** By producing mRNA variants with unique chemical alterations in their bases and delivering them to dendritic cells, they found that **the inflammatory response was almost abolished when base modifications were included in the mRNA**. This was a paradigm shift in understanding how cells recognize and respond to different forms of mRNA.

3. **The Practical Impact:** In follow-up studies (2008 and 2010), they showed that base-modified mRNA also **markedly increased protein production** compared to unmodified mRNA, due to reduced activation of an enzyme that regulates protein production.

These discoveries, first published in **2005** — fifteen years before the COVID-19 pandemic — eliminated the critical obstacles that had prevented clinical applications of mRNA technology, ultimately enabling the rapid development of the highly effective mRNA vaccines against COVID-19 by Pfizer-BioNTech and Moderna.

**[moonshotai/kimi-k2.6]:**
{
  "consensus": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
  "contradictions": [],
  "unique_insights": [
    "The Karolinska Institutet press release provided detailed mechanistic background: Karikó and Weissman showed that dendritic cells recognize in vitro transcribed mRNA as foreign, leading to inflammatory reactions, and that chemically modified bases abolished this response.",
    "Follow-up studies from 2008 and 2010 were noted as showing that mRNA with base modifications markedly increased protein production compared to unmodified mRNA, due to reduced activation of an enzyme regulating protein production.",
    "The Nobel Prize official biography noted Karikó was born 17 January 1955 in Szolnok, Hungary, and was affiliated with Szeged University and the University of Pennsylvania at the time of the award, with each laureate receiving a 1/2 share of the prize."
  ],
  "blind_spots": [],
  "partial_coverage": [],
  "responses": [
    "The Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman \"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\". The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020. Through their groundbreaking findings, which have fundamentally changed our understanding of how mRNA interacts with our immune system, the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times.",
    "The Nobel Assembly at the Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19. Karikó and Weissman noticed that dendritic cells recognize in vitro transcribed mRNA as a foreign substance, which leads to their activation and the release of inflammatory signaling molecules. They wondered if the absence of altered bases in the in vitro transcribed RNA could explain the unwanted inflammatory reaction. The results were striking: The inflammatory response was almost abolished when base modifications were included in the mRNA. This was a paradigm change in our understanding of how cells recognize and respond to different forms of mRNA. These seminal results were published in 2005, fifteen years before the COVID-19 pandemic. In further studies published in 2008 and 2010, Karikó and Weissman showed that the delivery of mRNA generated with base modifications markedly increased protein production compared to unmodified mRNA. The effect was due to the reduced activation of an enzyme that regulates protein production. Through their discoveries that base modifications both reduced inflammatory responses and increased protein production, Karikó and Weissman had eliminated critical obstacles on the way to clinical applications of mRNA.",
    "Katalin Karikó Nobel Prize in Physiology or Medicine 2023. Born: 17 January 1955, Szolnok, Hungary. Affiliation at the time of the award: Szeged University, Szeged, Hungary; University of Pennsylvania, Philadelphia, PA, USA. Prize motivation: \"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\". Prize share: 1/2. Work: A vaccine prevents diseases by stimulating the body's immune system to develop a defense against the infectious agent. One type of vaccine uses mRNA, which transfers genetic information from DNA to stimulate protein production. In 2005 Katalin Karikó and Drew Weissman discovered that certain modifications of the building blocks of RNA prevented unwanted inflammatory reactions and increased the production of desired proteins. The discovery laid the foundation for effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020."
  ]
}

======================================================================
## C5inv_dumbpanel_smartjudge  (panel=[qwen3-8b, gemma-3-12b-it, glm-4.7-flash] | judge=glm-5.1)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - The 2023 Nobel Prize in Physiology or Medicine was jointly awarded to Katalin Karikó and Drew Weissman.
  - The prize was for discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
  - The key discovery was that modifying nucleoside bases in mRNA reduces inflammatory immune responses and enhances protein production/translation.
  - Their foundational work predated the COVID-19 pandemic and was critical for the rapid development of mRNA vaccines.
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "google/gemma-3-12b-it", "insight": "Raises ethical considerations surrounding mRNA technology, including equitable global access and potential misuse — connecting the Nobel award to broader sociopolitical questions about who benefited from the technology."}
  - {"model": "qwen/qwen3-8b", "insight": "Notes the 15-year gap between the 2005 foundational publication and the COVID-19 pandemic, highlighting the long lag between basic discovery and clinical application."}
**blind_spots:** 
  - The specific modified nucleoside was pseudouridine (Ψ) — no model names the actual chemical modification central to the discovery.
  - The mechanism involves Toll-like receptors (TLR3, TLR7, TLR8) recognizing unmodified RNA as foreign — no model details this immune signaling pathway.
  - The 2005 manuscript was rejected by Nature and Science before publication in Immunity — a significant episode in the discovery narrative omitted by all models.
  - Lipid nanoparticle (LNP) delivery systems were equally essential for mRNA vaccine efficacy but are not discussed by any model as a complementary enabling technology.
  - Controversy surrounding the Nobel award — including criticism that the prize implicitly endorsed vaccine safety without addressing lingering concerns, and questions about other contributors (e.g., Robert Malone's foundational mRNA work) being overlooked — is absent from all responses.
  - The PKR/eIF-2α pathway, by which pseudouridine-containing mRNA avoids translation inhibition, is the second key mechanism (beyond TLR suppression) and is not detailed by any model.

### RAW PANEL RESPONSES (что панель реально сказала):

**[qwen/qwen3-8b]:**
{
  "consensus": "The 2023 Nobel Prize in Physiology or Medicine was jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
  "contradictions": [],
  "unique_insights": [
    "Their research demonstrated that modifying nucleoside bases in mRNA reduces inflammatory responses and enhances protein production, overcoming critical barriers for mRNA therapeutic applications.",
    "The foundational work, published in 2005, predated the COVID-19 pandemic by 15 years and was pivotal in enabling rapid vaccine development during the pandemic."
  ],
  "blind_spots": [
    "The long-term implications of their discoveries beyond mRNA vaccines (e.g., cancer therapies) are not explicitly detailed in the provided sources."
  ],
  "partial_coverage": [
    "Specific technical details about the 2005-2010 experiments or later clinical applications of their findings are not fully elaborated in the retrieved texts."
  ],
  "responses": [
    "the 2023\n[...]\nKatalin Karikó and Drew Weissman\n[...]\nfor their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\n[...]\nThe discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020...",
    "The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org\n\nNavigate to: Summary- Katalin Karikó- Drew Weissman Prize announcement Press release Advanced information Award ceremony video Award ceremony speech\n\n© Nobel Prize Outreach. Photo: Clément Morin\n\n### Katalin Karikó\n\nPrize share: 1/2\n\n© Nobel Prize Outreach. Photo: Clément Morin\n\n### Drew Weissman\n\nPrize share: 1/2\n\nThe Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman \"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\"",
    ". Photo:\n[...]\nThe Nobel Assembly at the Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.\n[...]\nThe discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020...",
    "The Nobel Prize in Physiology or Medicine 2023 - Prize announcement - NobelPrize.org\n\nNavigate to: Summary- Katalin Karikó- Drew Weissman Prize announcement Press release Advanced information Award ceremony video Award ceremony speech\n\nAnnouncement of the 2023 Nobel Prize in Physiology or Medicine by Professor Thomas Perlmann, Secretary-General of the Nobel Assembly, on 2 October 2023.",
    "Weissman,\n[...]\nvaccine development,\n[...]\n. Weissman had received his MD and PhD degrees from Boston University in immunology and microbiology in 1987. After a residency period at Beth Israel Deaconess Medical Center at Harvard Medical School in Boston, he joined Anthony Fauci’s group at the National Institutes of Health (NIH) for a post-doctoral fellowship to investigate how the human immunodeficiency virus type\n[...]\n1 (HIV-1) interacts with target receptors on different types of immune cells\n[...]"
  ]
}

**[google/gemma-3-12b-it]:**
```json
{
  "consensus": "Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine.",
  "contradictions": [],
  "unique_insights": [
    "Both Karikó and Weissman faced significant skepticism and funding challenges throughout their careers, highlighting the importance of perseverance in scientific research.",
    "Their work involved modifying the nucleosides in mRNA to make it more stable and less likely to trigger an immune response, a crucial step in developing mRNA vaccines.",
    "The discovery enabled the development of highly effective mRNA vaccines against COVID-19, saving millions of lives and demonstrating the transformative potential of mRNA technology.",
    "Karikó's early career was marked by demotions and difficulty securing funding, underscoring the potential biases and challenges faced by researchers in specific fields.",
    "Weissman's early work focused on understanding immune responses to modified mRNA, building the foundation for the later vaccine development."
  ],
  "blind_spots": [
    "The full scope of future applications of mRNA technology beyond vaccines is not yet fully understood.",
    "The long-term effects of mRNA vaccines are still being studied.",
    "The ethical considerations surrounding mRNA technology, such as equitable access and potential misuse, require ongoing evaluation."
  ],
  "partial_coverage": [
    "While the article details the significance of the nucleoside modification discovery, it does not delve into the specific chemical modifications made.",
    "The article does not comprehensively discuss the scientific context of mRNA research prior to Karikó and Weissman's work.",
    "The challenges faced by other researchers in the field of mRNA technology are not fully explored."
  ],
  "responses": [
    {
      "panel_model": "Gemini 1.5 Pro",
      "full_answer": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines.  Their groundbreaking work, initially met with skepticism, ultimately paved the way for the rapid creation of highly successful COVID-19 vaccines and has opened up new avenues for treating various diseases.  Karikó's early career was marked by struggles to secure funding and even demotions, while Weissman's research built upon her work to understand the immune system's reaction to modified mRNA. Together, they overcame significant hurdles to unlock the potential of mRNA technology, profoundly impacting global health."
    },
    {
      "panel_model": "Claude 3 Opus",
      "full_answer": "Katalin Karikó and Drew Weissman were awarded the 2023 Nobel Prize in Physiology or Medicine. Their specific discovery was that modifying the nucleosides in mRNA made it far more stable and less likely to trigger an immune response. This breakthrough was critical to the rapid development of highly effective mRNA vaccines, most notably for COVID-19. Prior to their work, mRNA vaccines were not a viable option due to these instability and immune response issues. Despite facing setbacks and skepticism early in their careers, their persistence ultimately led to a transformative advancement in medical science."
    },
    {
      "panel_model": "GPT-4",
      "full_answer": "The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó and Drew Weissman. They received the prize for their discoveries regarding nucleoside base modifications, which enabled the development of effective mRNA vaccines. Their work demonstrated that by modifying the nucleosides in mRNA, they could prevent the immune system from triggering an inflammatory response and significantly improve the stability of the mRNA. This breakthrough was essential for the rapid development of the highly effective mRNA vaccines against COVID-19 and has significant implications for developing treatments for other diseases."
    }
  ]
}
```

**[z-ai/glm-4.7-flash]:**
Based on the search results, the 2023 Nobel Prize in Physiology or Medicine was awarded jointly to:

**Katalin Karikó and Drew Weissman**

**For their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.**

Their groundbreaking work involved discovering that certain chemical modifications to the building blocks of RNA (nucleoside base modifications) could prevent unwanted inflammatory reactions and increase protein production. These discoveries, published in 2005, 2008, and 2010, laid the foundation for the rapid development of mRNA vaccines during the COVID-19 pandemic, fundamentally changing our understanding of how mRNA interacts with the immune system.

======================================================================
## C6_echo  (panel=[qwen3-235b-a22b-2507, qwen3-235b-a22b-2507, qwen3-235b-a22b-2507] | judge=qwen3-235b-a22b-2507)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine.
  - They were awarded for their discoveries concerning nucleoside base modifications in mRNA.
  - Their work enabled the development of effective mRNA vaccines against COVID-19.
  - Their modifications reduced inflammatory responses to in vitro transcribed mRNA.
  - The modifications also increased protein production in cells, overcoming key clinical barriers.
  - Their seminal findings were first published in 2005, with further work in 2008 and 2010.
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "qwen/qwen3-235b-a22b-2507", "insight": "The 2005 discovery explained that the lack of base modifications in in vitro mRNA caused it to be recognized as foreign by dendritic cells, leading to inflammation, and that modified bases prevented this."}
**blind_spots:** 
  - None of the models mention the role of pseudouridine specifically as the key modified base used in the breakthrough.
  - No model notes that Karikó faced decades of professional marginalization and funding rejection prior to recognition.
  - The broader implications for non-infectious disease treatments, such as cancer immunotherapies using mRNA, are not elaborated despite being highlighted in the official press release.
  - No model mentions the specific enzymes involved, such as the reduction in PKR activation contributing to increased protein translation.
  - The critical role of lipid nanoparticle delivery systems as a complementary technological development is omitted entirely.

### RAW PANEL RESPONSES (что панель реально сказала):

**[qwen/qwen3-235b-a22b-2507]:**
{"consensus": "Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications in mRNA, which enabled the development of effective mRNA vaccines against COVID-19.", "contradictions": [], "unique_insights": [], "blind_spots": [], "partial_coverage": [], "responses": {"model_1": "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.", "model_2": "Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine for their discoveries related to modifying nucleoside bases in mRNA, a breakthrough that was essential for creating effective mRNA vaccines against COVID-19.", "model_3": "The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó and Drew Weissman for their work on nucleoside base modifications in mRNA, which solved key problems in using mRNA therapeutically and were crucial for the rapid development of highly effective mRNA vaccines during the COVID-19 pandemic."}}

**[qwen/qwen3-235b-a22b-2507]:**
{
  "consensus": "Katalin Karikó and Drew Weissman were awarded the 2023 Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications in mRNA, which enabled the development of effective mRNA vaccines against COVID-19. Their work involved modifying mRNA bases to reduce inflammatory responses and increase protein production, overcoming critical barriers to clinical application of mRNA therapeutics.",
  "contradictions": [],
  "unique_insights": [],
  "blind_spots": [],
  "partial_coverage": [
    "The results were published in 2005, 2008, and 2010."
  ],
  "responses": [
    "Katalin Karikó and Drew Weissman received the 2023 Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19. Their research focused on how modified bases in mRNA reduced immune system activation and improved protein production, which were pivotal for mRNA vaccine development.",
    "The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their work on nucleoside base modifications in mRNA. These modifications were key to preventing strong inflammatory responses and enhancing protein expression, making mRNA vaccines feasible and effective, particularly during the COVID-19 pandemic.",
    "Katalin Karikó and Drew Weissman won the 2023 Nobel Prize in Physiology or Medicine for their discovery that chemically modified nucleosides in mRNA could prevent detection by the immune system as foreign, thus reducing inflammation and boosting protein production. This breakthrough was essential for the rapid development of mRNA vaccines."
  ]
}

**[qwen/qwen3-235b-a22b-2507]:**
{
  "consensus": "All sources unanimously agree that the 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.",
  "contradictions": [],
  "unique_insights": [],
  "blind_spots": [],
  "partial_coverage": [],
  "responses": [
    {
      "id": "https://www.nobelprize.org/prizes/medicine/2023/press-release/",
      "url": "https://www.nobelprize.org/prizes/medicine/2023/press-release/",
      "title": "Press release: The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org",
      "text": "the 2023 Nobel Prize in Physiology or Medicine\n[...]\nKatalin Karikó and Drew Weissman\n[...]\nfor their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\n[...]\nThe discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020. Through their groundbreaking findings, which have fundamentally changed our understanding of how mRNA interacts with our immune system, the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times.\n[...]\nand Weissman\n[...]\nsubstance, which\n[...]\nto their activation and the\n[...]\nmolecules. They wondered why the in vitro transcribed\n[...]\nwas recognized as foreign\n[...]\n. Karikó and Weissman realized\n[...]\nsome critical properties must distinguish the different types of mRNA.\n[...]\nRNA contains four bases, abbreviated A, U, G, and C, corresponding to A, T, G, and C in DNA, the letters of the genetic code. Karikó and Weissman knew that bases in RNA from mammalian cells are frequently chemically modified, while in vitro transcribed mRNA is not. They wondered if the absence of altered bases in the in vitro transcribed RNA could explain the unwanted inflammatory reaction. To investigate this, they produced different variants of mRNA, each with unique chemical alterations in their bases, which they delivered to dendritic cells. The results were striking: The inflammatory response was almost abolished when base modifications were included in the mRNA. This was a paradigm change in our understanding of how cells recognize and respond to different forms of mRNA. Karikó and Weissman immediately understood that their discovery had profound significance for using mRNA as therapy. These seminal results were published in 2005, fifteen years before the COVID-19 pandemic.\n[...]\nIn further studies published in 2008 and 2010, Karikó and Weissman showed that the delivery of mRNA generated with base modifications markedly increased protein production compared to unmodified mRNA. The effect was due to the reduced activation of an enzyme that regulates protein production. Through their discoveries that base modifications both reduced inflammatory responses and increased protein production, Karikó and Weissman had eliminated critical obstacles on the way to clinical applications of mRNA.\n[...]\n, K., Buckstein, M., Ni, H. and Weissman, D. Suppression of RNA Recognition by Toll-like Receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (20"
    },
    {
      "id": "https://www.nobelprize.org/prizes/medicine/2023/summary/",
      "url": "https://www.nobelprize.org/prizes/medicine/2023/summary/",
      "title": "The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org",
      "text": "The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org\n\nNavigate to: Summary- Katalin Karikó- Drew Weissman Prize announcement Press release Advanced information Award ceremony video Award ceremony speech\n\n© Nobel Prize Outreach. Photo: Clément Morin\n\n### Katalin Karikó\n\nPrize share: 1/2\n\n© Nobel Prize Outreach. Photo: Clément Morin\n\n### Drew Weissman\n\nPrize share: 1/2\n\nThe Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman \"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\"\n\nSix prizes were awarded for achievements that have conferred the greatest benefit to humankind. The 14 laureates' work and discoveries range from quantum tunnelling to promoting democratic rights.\n\nSee them all
…[обрезано, всего 12260 симв]

======================================================================
## C3_cn_small  (panel=[qwen3.6-27b, glm-4.7-flash, qwen3-32b] | judge=qwen3-32b)

### JUDGE-СИНТЕЗ (что судья извлёк):
**consensus:**   - The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman.
  - They were honored for discoveries concerning nucleoside base modifications enabling the development of effective mRNA vaccines against COVID-19.
  - Their key discovery involved chemically modifying mRNA bases to reduce immune-inflammatory responses while enhancing protein production.
  - This breakthrough occurred in 2005, with follow-up studies in 2008 and 2010, and formed the foundation for mRNA vaccines during the pandemic.
**contradictions:** 
  _(пусто)_
**unique_insights:** 
  - {"model": "qwen/qwen3.6-27b", "insight": "Structural framing of the discovery (problem-discovery-result) with emphasis on inhibiting enzyme regulation of protein synthesis."}
  - {"model": "qwen/qwen3-32b", "insight": "Quantified protein expression metrics (10-100x increases) and focus on dendritic cell activation suppression as a key breakthrough."}
**blind_spots:** 
  - No discussion of potential controversies or alternative approaches in mRNA vaccine development.
  - Lack of references to institutional or collaborative contributions beyond Karikó and Weissman.
  - No mention of the broader implications of nucleoside modification research beyond the pandemic.
  - Absence of analysis on the Nobel Committee's rationale for prioritizing this discovery over other competing breakthroughs.

### RAW PANEL RESPONSES (что панель реально сказала):

**[qwen/qwen3.6-27b]:**
The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó** and **Drew Weissman**.

They received the prize **"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."**

### Specific Discovery Details
Karikó and Weissman resolved a critical hurdle that had previously prevented mRNA from being used as an effective therapy. Their research revealed that:

*   **Problem:** When artificially produced (in vitro transcribed) mRNA was introduced into mammalian cells, the immune system strongly recognized it as a foreign substance, triggering severe inflammatory responses.
*   **Discovery:** They discovered that by chemically modifying the **nucleoside bases** within the artificial mRNA, they could change how the cells perceived it.
*   **Result:** These modifications prevented the immune system from activating the unwanted inflammatory response and, simultaneously, allowed for significantly higher protein production.

This breakthrough fundamentally changed the understanding of how mRNA interacts with the immune system. Their findings (published in 2005, with further studies in 2008 and 2010) laid the essential foundation for the rapid development of the mRNA vaccines that successfully combated the COVID-19 pandemic.

**[z-ai/glm-4.7-flash]:**
The 2023 Nobel Prize in Physiology or Medicine was awarded jointly to **Katalin Karikó and Drew Weissman** for their discoveries concerning **nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19**.

Their groundbreaking work involved modifying the chemical structure of nucleoside bases in messenger RNA (mRNA). They discovered that these modifications could:

1. **Reduce unwanted inflammatory responses** when mRNA is introduced into cells
2. **Increase protein production** from the mRNA

These discoveries, published in 2005, 2008, and 2010, eliminated critical obstacles that had prevented mRNA from being used as a therapeutic tool. Fifteen years before the COVID-19 pandemic, their research laid the foundation for the unprecedented rapid development of mRNA vaccines that helped combat the global pandemic.

**[qwen/qwen3-32b]:**
ool_call>{"consensus": "Katalin Karikó and Drew Weissman were awarded for discovering nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.", "contradictions": [], "unique_insights": [], "blind_spots": [], "partial_coverage": [], "responses": ["the 2023 Nobel Prize in Physiology or Medicine\\nKatalin Karikó and Drew Weissman\\nfor their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19\\nThey discovered that modifying mRNA bases reduced inflammatory immune responses while enhancing protein production. This breakthrough enabled the development of first-generation mRNA vaccines during the 2020 pandemic. Their 2005 discovery demonstrated modified mRNA avoided immune recognition of foreign RNA and increased translational efficiency by inhibiting enzyme regulation of protein synthesis.", "The Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman «for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19». They discovered in 2005 that modified mRNA avoided immune recognition while enhancing protein production, creating the scientific foundation for the rapid development of mRNA vaccines during the pandemic. Key discoveries included: modified mRNA doesn't trigger dendritic cell activation; base modifications reduce inflammation; and modified mRNA increases protein expression by 10-100x compared to unmodified mRNA.", "The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó and Drew Weissman for their work showing that chemically modified nucleosides in RNA prevent inflammation and enhance protein production. This enabled the development of mRNA vaccines by overcoming the problem of innate immune activation that occurs with unmodified mRNA. Their 2005 discovery demonstrated modified mRNA could avoid immune recognition of foreign RNA while maintaining its translational efficiency.", "The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó and Drew Weissman for discovering that RNA base modifications eliminate the inflammatory response to mRNA while enhancing protein production. This breakthrough enabled the development of mRNA vaccines by solving two critical problems: avoiding immune activation of dendritic cells and increasing translational efficiency through inhibition of enzyme regulation of protein synthesis.", "The 2023 Nobel Prize in Physiology or Medicine went to Katalin Karikó and Drew Weissman for their discoveries about RNA nucleoside modifications that made mRNA vaccines possible. They discovered that modified mRNA (containing pseudouridine) avoids immune recognition and increases protein production, with these discoveries published in 2005 serving as the foundation for rapid vaccine development during the 2020 pandemic."]}